tiprankstipranks
Accuray Incorporated (ARAY)
NASDAQ:ARAY
US Market

Accuray (ARAY) Stock Investors

Compare
794 Followers
Based on 794,241 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ARAY
On average, investors allocate 2.53% of their portfolios to ARAY
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 794,241 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ARAY

2.7%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ARAY, out of 794,241 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ARAY Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$2.29
Based on the activity of investors who made their portfolios public
The table shows changes in ARAY in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ARAY Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Nio
8.88%
-1.18%
-0.37%
7.80B
Consumer Cyclical
Lucid Group
5.43%
-0.02%
+1.15%
7.67B
Consumer Cyclical
Block
3.60%
-0.57%
+3.85%
33.66B
Technology
Abbott Laboratories
3.50%
-0.66%
+0.13%
230.06B
Healthcare
UiPath
3.28%
-1.23%
-1.76%
5.68B
Technology
CVS Health
4.38%
-0.62%
-1.52%
85.71B
Healthcare
Ford Motor
5.68%
-0.77%
-0.29%
39.40B
Consumer Cyclical
Marathon Digital Holdings
4.93%
-0.69%
-0.81%
4.09B
Financial
Viking Therapeutics
3.79%
-0.83%
-2.93%
2.71B
Healthcare
Riot Platforms
4.57%
-1.17%
-1.95%
2.64B
Financial
Based on the activity of 794,241 active portfolios
Open your Smart Portfolio

ARAY Investor Analysis

ARAY investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.6%
of ARAY holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
ARAY investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.6%
of ARAY holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
ARAY investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
46.8%
of ARAY holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of ARAY stock investors
See who invests in ARAY according to age group and performance.

FAQ

How many retail Investors hold ARAY?
<0.1% of TipRanks' retail investors hold ARAY in their portfolios.
    What is ARAY Investor Sentiment?
    ARAY’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ARAY in the last 7 days?
      ▼ 2.7% of TipRanks' retail investors changed their holding of ARAY in the last 7 days.
        What percentage of retail investors changed their holding of ARAY in the last 30 days?
        ▼ 3.0% of TipRanks' retail investors changed their holding of ARAY in the last 30 days.
          What is the average age of retail investors who hold ARAY?
          The average age of ARAY Holders is over 55.
            What other stocks have ARAY investors also bought?
            ARAY Investors also bought NIO, LCID, XYZ, ABT, PATH, CVS, F, MARA, VKTX, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              CORCencora
              LCTXLineage Therap
              CNCCentene
              ELMDElectromed
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis